|1.||Schreiner, Ceinwen A: 1 article (11/2014)|
|2.||Trimmer, Gary W: 1 article (11/2014)|
|3.||Clark, Charles R: 1 article (11/2014)|
|4.||Gray, Thomas M: 1 article (11/2014)|
|5.||Murray, F Jay: 1 article (11/2014)|
|6.||Parker, Robert M: 1 article (11/2014)|
|7.||Roberts, Linda G: 1 article (11/2014)|
|8.||Guirelli, Isabella: 1 article (01/2011)|
|9.||Machado, Luiz Fernando Almeida: 1 article (01/2011)|
|10.||Freitas, Felipe Bonfim: 1 article (01/2011)|
03/01/2005 - "It is proposed that the pleiotropic effects of DIME (or DIPE) on cancer cells involve the activation of protein dephosphorylations, as well as inhibition of tubulin polymerization."
07/01/1998 - "Drug interaction between DIME or DIPE ¿1-[3, 5-diiodo-4-(4'-methoxyphenoxy)-phenyl]-ethanone¿ with vincristine and vinblastine on the growth rate of MDA-MB-231 human mammary cancer cells was determined by the median effect kinetic method. "
07/01/1998 - "Unusual potentiation by vinca alkaloids of the cytostatic and cytocidal action of methyl-3,5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME) and its nonhydrolyzable ethanone analog (DIPE) on MDA-MB-231 human mammary cancer cells."
|2.||Body Weight (Weight, Body)
09/01/1996 - "Exposure to DIPE did not adversely affect clinical signs, body weight, serum chemistry, hematology, or the number of sperm or spermatids. "
12/01/2002 - "Di-isopropyl ether (DIPE) was administered in the same manner at the doses of 1000, 250, or 0 mg/kg body weight to groups of 100 male and 100 female Sprague-Dawley rats. "
11/01/2014 - "Developmental effects occurred at 20,000mg/m(3) of G/TAME (reduced fetal body weight, increased incidence of stunted fetuses), G/TBA (reduced fetal body weight, increased skeletal variants) and G/DIPE (reduced fetal weight) resulting in developmental NOAEL of 10,000mg/m(3) for these materials. "
|4.||Parasitic Diseases (Parasitic Disease)
|3.||Vinblastine (Vinblastine Sulfate)